Skip to content
healthcare.dev

Guaifenesin and Pseudoephedrine HCL

NDC 55111-798, Guaifenesin and Pseudoephedrine HCL, tablet, extended release, from Dr. Reddys Laboratories Limited.

Product NDC
55111-798
Status
Listed
Labeler
Dr. Reddys Laboratories Limited
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA208369
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55111-798 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN600 mg/1
  • PSEUDOEPHEDRINE HYDROCHLORIDE60 mg/1

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; alpha-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
55111-798-09551110798091 BLISTER PACK in 1 CARTON (55111-798-09) / 9 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
55111-798-18551110798182 BLISTER PACK in 1 CARTON (55111-798-18) / 9 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
55111-798-35551110798351 BLISTER PACK in 1 CARTON (55111-798-35) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
55111-798-36551110798364 BLISTER PACK in 1 CARTON (55111-798-36) / 9 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
55111-798-41551110798412 BLISTER PACK in 1 CARTON (55111-798-41) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 55111079818

    GET /v1/drugs/nadac/55111079818
  • NADAC price for package 55111079835

    GET /v1/drugs/nadac/55111079835
  • NADAC price for package 55111079836

    GET /v1/drugs/nadac/55111079836
  • NADAC price for package 55111079841

    GET /v1/drugs/nadac/55111079841

Use it

Look up 55111-798 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55111-798 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55111-798. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.